Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Inozyme Pharma, Inc. See All Filings	D/A	2020-06-08 13:09:29 UTC
Amount To Be Raised $67,399,993 Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-20-000004 Exclusions or Exemptions 506b Accepted Date 2020-06-08 13:09:29 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Inozyme Pharma, Inc. See All Filings	D/A	2020-03-27 11:41:00 UTC
Amount To Be Raised $33,699,996 Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-03-27 11:41:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Inozyme Pharma, Inc. See All Filings	D/A	2019-03-29 15:16:17 UTC
Amount To Be Raised $33,699,996 Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-03-29 15:16:17 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Inozyme Pharma, Inc. See All Filings	D	2018-11-21 16:22:42 UTC
Amount To Be Raised $10,699,996 Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-18-000004 Exclusions or Exemptions 506b Accepted Date 2018-11-21 16:22:42 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Inozyme Pharma, Inc. See All Filings	D/A	2018-11-21 16:20:01 UTC
Amount To Be Raised $48,850,000 Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-18-000003 Exclusions or Exemptions 506b Accepted Date 2018-11-21 16:20:01 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Inozyme Pharma, Inc. See All Filings	D/A	2017-01-12 10:23:55 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-17-000003 Exclusions or Exemptions 506b Accepted Date 2017-01-12 10:23:55 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets $No Revenues Type of Security Equity
Inozyme Pharma, LLC See All Filings	D	2017-01-05 16:21:10 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001693011 Filed Document 0001693011-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-01-05 16:21:10 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets $No Revenues Type of Security Equity